HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use LEVETIRACETAM INJECTION safely and effectively. See full prescribing information for LEVETIRACETAM INJECTION.
LEVETIRACETAM injection, for intravenous use
Initial U.S. Approval: 1999
INDICATIONS AND USAGE
DOSAGE AND ADMINISTRATION
Levetiracetam injection is for intravenous use only (2.1)
Partial-Onset Seizures (monotherapy or adjunctive therapy)
Myoclonic Seizures in Adults and Pediatric Patients 12 Years and Older
Primary Generalized Tonic-Clonic Seizures
Switching From or To Oral Levetiracetam
DOSAGE FORMS AND STRENGTHS
Injection: 500 mg/5 mL single-dose vial. (3)
WARNINGS AND PRECAUTIONS
Most common adverse reactions (incidence ≥ 5% more than placebo) include:
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer, Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
USE IN SPECIFIC POPULATIONS
See 17 for PATIENT COUNSELING INFORMATION.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.